187 related articles for article (PubMed ID: 9075223)
1. The costs of dialysis in the USA.
Garella S
Nephrol Dial Transplant; 1997; 12 Suppl 1():10-21. PubMed ID: 9075223
[TBL] [Abstract][Full Text] [Related]
2. Impact of reimbursement regulations on patient management.
Hull AR
Am J Kidney Dis; 1992 Jul; 20(1 Suppl 1):8-11. PubMed ID: 1626555
[TBL] [Abstract][Full Text] [Related]
3. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
Anantharaman P; Moss AH
Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
[TBL] [Abstract][Full Text] [Related]
4. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
5. The financial implications for Medicare of greater use of peritoneal dialysis.
Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
[TBL] [Abstract][Full Text] [Related]
6. A quarter century of medicare expenditures for ESRD.
Eggers PW
Semin Nephrol; 2000 Nov; 20(6):516-22. PubMed ID: 11111852
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of end stage renal disease and implications for public policy.
Rubin RJ
Public Health Rep; 1984; 99(5):492-8. PubMed ID: 6435162
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and cost implications of inadequate hemodialysis.
Sehgal AR; Dor A; Tsai AC
Am J Kidney Dis; 2001 Jun; 37(6):1223-31. PubMed ID: 11382692
[TBL] [Abstract][Full Text] [Related]
9. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers.
Schon D; Blume SW; Niebauer K; Hollenbeak CS; de Lissovoy G
Clin J Am Soc Nephrol; 2007 Mar; 2(2):268-76. PubMed ID: 17699424
[TBL] [Abstract][Full Text] [Related]
10. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
Bhat P; Sokolowski W; Bhat JG
Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
[TBL] [Abstract][Full Text] [Related]
11. Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.
Brown J; Josephson M
Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S85-94. PubMed ID: 11053593
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of dialysis therapies.
Klarenbach S; Manns B
Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
[TBL] [Abstract][Full Text] [Related]
13. How dialysis is paid for: what the dialysis medical director should know, and why.
Deoreo PB
Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
[TBL] [Abstract][Full Text] [Related]
14. Kidney Failure? Dialysis is the only medical service without automatic inflation updates from Medicare. Some people are trying to change that.
Zigmond J
Mod Healthc; 2006 Nov; 36(44):6-7, 14-6, 1. PubMed ID: 17128943
[TBL] [Abstract][Full Text] [Related]
15. Care of undocumented individuals with ESRD: a national survey of US nephrologists.
Hurley L; Kempe A; Crane LA; Davidson A; Pratte K; Linas S; Dickinson LM; Berl T
Am J Kidney Dis; 2009 Jun; 53(6):940-9. PubMed ID: 19327878
[TBL] [Abstract][Full Text] [Related]
16. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
Hornberger J; Hirth RA
Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829
[TBL] [Abstract][Full Text] [Related]
17. Barriers to the delivery of adequate hemodialysis in ESRD Network 4.
Palevsky PM; Washington MS; Stevenson JA; Rohay JM; Dyer NJ; Lockett R; Perry SB
Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S11-20. PubMed ID: 11053582
[TBL] [Abstract][Full Text] [Related]
18. Understanding the basic case-mix adjustment for the composite rate.
Wheeler JR; Messana JM; Turenne MN; Hirth RA; Pozniak AS; Pan Q; Chuang CC; Slish K; Tedeschi P; Roys EC; Wolfe RA
Am J Kidney Dis; 2006 Apr; 47(4):666-71. PubMed ID: 16564944
[TBL] [Abstract][Full Text] [Related]
19. Improved hepatitis B vaccination rates in ESRD patients in California.
Brown J; Peters V
Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S95-9. PubMed ID: 11053594
[TBL] [Abstract][Full Text] [Related]
20. Medicare program; end-stage renal disease quality incentive program. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2011 Jan; 76(3):627-46. PubMed ID: 21261127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
